SREBF1 and fatty liver disease: Interestingly, PPARg2 but not SREBP1c expression was elevated in middle-aged vs. aged AHKO liver, indicating that hepatic PPARg2 was the driver of increased de novo lipogenesis and the pathogenesis of fatty liver in these mice.